ResMed
661 hedge funds and large institutions have $23.9B invested in ResMed in 2021 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 200 increasing their positions, 255 reducing their positions, and 65 closing their positions.
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
32% more call options, than puts
Call options by funds: $82.1M | Put options by funds: $62.3M
24% more capital invested
Capital invested by funds: $19.2B → $23.9B (+$4.62B)
9% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 65
0% less funds holding
Funds holding: 662 → 661 (-1)
1.62% less ownership
Funds ownership: 68.27% → 66.65% (-1.6%)
22% less repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 255
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
+$93.4M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.9M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$49.2M |
| 4 |
Millennium Management
New York
|
+$40.6M |
| 5 |
Morgan Stanley
New York
|
+$37.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$158M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$88.3M |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
-$70.3M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$58.4M |
| 5 |
JP Morgan Chase
New York
|
-$50.5M |
RMD Hedge Fund Activity: Q2 2021 in Review
661 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q2 2021, worth a combined $23.9B — up 24% from $19.2B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new RMD positions and 65 closed out — a net gain of 6 holders — while 200 added to existing stakes and 255 trimmed.
The largest buyer was Ownership Capital B.V., adding an estimated $93.4M. The largest seller was BlackRock, cutting an estimated $158M.
- 661 institutional investors held ResMed (RMD) as of Q2 2021, down from 662 in Q1 2021.
- Funds reported $23.9B of ResMed stock for Q2 2021, up 24% quarter-over-quarter.
- 71 funds opened new ResMed positions in Q2 2021 and 65 closed out, a net change of +6 holders.
- The largest ResMed buyer in Q2 2021 was Ownership Capital B.V., an estimated $93.4M added.
- The largest ResMed seller in Q2 2021 was BlackRock, an estimated $158M sold.
Based on aggregated 13F filings for Q2 2021.